earnings
saveASTRAZENECA PLC earnings
community read0 votes
Anticipated earnings call for ASTRAZENECA PLC ($AZN).
view source ↗Data sources
Found something off?
same company · ±60 days · 6
- phase 3 completiondurvalumab: AstraZeneca Plc — durvalumab (Phase III Trial Completion)Apr 29, 2026
- fda advisory committee meetingcamizestrant: AstraZeneca Plc — camizestrant (FDA Advisory Committee Meeting)Apr 30, 2026
- phase 1 2 completionCALQUENCE: AstraZeneca Plc — Calquence (Phase I/II Trial Completion)Apr 30, 2026
- phase 2 completiontozorakimab: AstraZeneca Plc — tozorakimab (Phase II Trial Completion)Apr 30, 2026
- fda advisory committee meetingcapivasertib: AstraZeneca Plc — capivasertib (FDA Advisory Committee Meeting)Apr 30, 2026
- approvaleplontersen sodium: WAINUA (AUTOINJECTOR) (EPLONTERSEN SODIUM) — FDA approvalApr 15, 2026
🐶 often sniffed alongside
top 8- tagOncology15 co-mentions · 4 sources
- tagNephrology3 co-mentions · 1 sources
- tagNeurology3 co-mentions · 1 sources
- tagPsychiatry & CNS3 co-mentions · 1 sources
- tagBreast Cancer2 co-mentions · 1 sources
- tagCOPD2 co-mentions · 1 sources
- tagAdCom2 co-mentions · 2 sources
- tagPulmonology2 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that